Literature DB >> 22551306

Mechanistic insight into pertussis toxin and lectin signaling using T cells engineered to express a CD8α/CD3ζ chimeric receptor.

Olivia D Schneider1, Scott H Millen, Alison A Weiss, William E Miller.   

Abstract

Mammalian cell-surface receptors typically display N- or O-linked glycans added post-translationally. Plant lectins such as phytohemagluttinin (PHA) can activate the T cell receptor (TCR) and other cell-surface receptors by binding to glycans and initiating receptor cross-linking. Pathogenic microorganisms such as Bordetella pertussis also express proteins with lectin-like activities. Similar to plant lectins, pertussis toxin (PTx) can activate the TCR and bind to a variety of glycans. However, whether the lectin-like activity of PTx is responsible for its ability to activate TCR signaling has not been formally proven. Here we examined the ability of PTx and a panel of lectins to activate the TCR or a CD8α/CD3ζ chimeric receptor (termed CD8ζ). We demonstrate that CD8ζ rescues PTx-induced signaling events lacking in TCR null cells. This result indicates that CD8ζ can substitute for TCR and supports the hypothesis that PTxB (functioning as a lectin) stimulates signaling via receptor cross-linking rather than by binding to a specific epitope on the TCR. Moreover, PTx is able to activate signaling by binding either N-linked or O-linked glycan-modified receptors as the TCR displays N-linked glycans while CD8ζ displays O-linked glycans. Finally, studies with a diverse panel of lectins indicate that the signaling activity of the lectins does not always correlate with the biochemical reports of ligand preferences. Comparison of lectin signaling through TCR or CD8ζ allows us to better define the structural and functional properties of lectin-glycan interactions using a biologically based signaling readout.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551306      PMCID: PMC3359064          DOI: 10.1021/bi3002693

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  68 in total

1.  The crystal structure of wheat germ agglutinin at 2-2 A resolution.

Authors:  C S Wright
Journal:  J Mol Biol       Date:  1977-04-25       Impact factor: 5.469

2.  Properties of succinylated wheat-germ agglutinin.

Authors:  M Monsigny; C Sene; A Obrenovitch; A C Roche; F Delmotte; E Boschetti
Journal:  Eur J Biochem       Date:  1979-07

3.  Distribution of the T-antigen on erythroid cell surfaces. Studies with peanut agglutinin, an anti-T specific lectin.

Authors:  E Skutelsky; R Lotan; N Sharon; D Danon
Journal:  Biochim Biophys Acta       Date:  1977-06-02

4.  Sugar-lectin interactions: how does wheat-germ agglutinin bind sialoglycoconjugates?

Authors:  M Monsigny; A C Roche; C Sene; R Maget-Dana; F Delmotte
Journal:  Eur J Biochem       Date:  1980-02

5.  Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.

Authors:  E L Hewlett; K T Sauer; G A Myers; J L Cowell; R L Guerrant
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines.

Authors:  G Yogeeswaran; P L Salk
Journal:  Science       Date:  1981-06-26       Impact factor: 47.728

7.  Mitogenic leukoagglutinin from Phaseolus vulgaris binds to a pentasaccharide unit in N-acetyllactosamine-type glycoprotein glycans.

Authors:  S Hammarström; M L Hammarström; G Sundblad; J Arnarp; J Lönngren
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Carbohydrate-binding specificity of the so-called galactose-specific phytohemagglutinins.

Authors:  T Irimura; T Kawaguchi; T Terao; T Osawa
Journal:  Carbohydr Res       Date:  1975-02       Impact factor: 2.104

9.  Peanut agglutinin, a new mitogen that binds to galactosyl sites exposed after neuraminidase treatment.

Authors:  A Novogrodsky; R Lotan; A Ravid; N Sharon
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

10.  The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.

Authors:  J H Morse; A S Kong; J Lindenbaum; S I Morse
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

View more
  6 in total

Review 1.  The Immune System of HIV-Exposed Uninfected Infants.

Authors:  Bahaa Abu-Raya; Tobias R Kollmann; Arnaud Marchant; Duncan M MacGillivray
Journal:  Front Immunol       Date:  2016-09-28       Impact factor: 7.561

2.  Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function.

Authors:  Scott H Millen; Mineo Watanabe; Eiji Komatsu; Fuminori Yamaguchi; Yuki Nagasawa; Eri Suzuki; Haleigh Monaco; Alison A Weiss
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

3.  Pertussis toxin B-pentamer mediates intercellular transfer of membrane proteins and lipids.

Authors:  Scott H Millen; Olivia D Schneider; William E Miller; John J Monaco; Alison A Weiss
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

4.  Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression.

Authors:  Bastian Robinson Baarz; Thea Laurentius; Jana Wolf; Inga Wessels; Leo Cornelius Bollheimer; Lothar Rink
Journal:  Immun Ageing       Date:  2022-08-30       Impact factor: 9.701

5.  Differential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. Delayed responses in Bordetella pertussis.

Authors:  Tuan M Nguyen; Dipti Ravindra; Brian Kwong; Sana Waheed; Ryan Ferguson; Nicole Tarlton; Victoria Wu; Christopher S Sequeira; Martina Bremer; Tzvia Abramson
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

6.  Complex human adenoid tissue-based ex vivo culture systems reveal anti-inflammatory drug effects on germinal center T and B cells.

Authors:  Angelika Schmidt; Johanna E Huber; Özen Sercan Alp; Robert Gürkov; Christoph A Reichel; Matthias Herrmann; Oliver T Keppler; Thomas Leeuw; Dirk Baumjohann
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.